Public drug program spending share for non-seniors in Canada by top drug classes 2018

Published by Matej Mikulic, Jan 3, 2020
This statistic displays the proportion of the top 10 drug classes based on total public drug program expenditures for non-seniors in Canada in 2018. In that year, 2.8 percent of total drug program spending for non-seniors was dedicated to drugs used in the treatment of opioid dependence.

Distribution of top 10 drug classes in Canada by total public drug program spending on non-seniors in 2018*

Share of total public drug program spending
Tumour necrosis factor alpha inhibitors (anti-TNF drugs)13.1%
Antivirals for treatment of hepatitis C infections**10.1%
Other antipsychotics4.7%
Selective immunosuppressants3.9%
Drugs used in opiod dependence2.8%
Centrally acting sympathomimetics2.6%
Antivirals for treatment of HIV infections, combinations***2.6%
Diazepines, oxazepines, thiazepines and oxepines2.4%
Other antiepileptics1.8%
Other immunosuppressants1.7%
Loading statistic...

Additional Information

© Statista 2020

Show source

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Show sources information
Show publisher information

Release date

December 2019

Region

Canada

Survey time period

2018

Special properties

non-elderly population

Supplementary notes

* Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.
** Spending on antivirals for treatment of hepatitis C infections in Prince Edward Island is not included in NPDUIS.
*** Spending on antivirals for treatment of HIV infections in Prince Edward Island, Nova Scotia, Alberta and British Columbia is not included in NPDUIS.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Government spending in the public sector in the UK"

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

Drug situation in EuropeDrug use in the U.S.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Menu